What is Repligen's operating cash flow?

Repligen (RGEN) reported operating cash flow of $28.3M in Q1 2026.

How has Repligen's operating cash flow changed year-over-year?

Repligen's operating cash flow increased by 88.6% year-over-year, from $15.01M to $28.3M.

What is the long-term trend for Repligen's operating cash flow?

Over 4 years (2021 to 2025), Repligen's operating cash flow has grown at a -0.3% compound annual growth rate (CAGR), from $119.02M to $117.42M.

What does operating cash flow mean?

Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

Repligen RGEN Operating Cash Flow

Operating Cash Flow at other companies

TEC

Bio-TechneTECH

$86.66M+111%

RevvityRVTY

$115.23M-10.1%

Thermo Fisher ScientificTMO

$1.19B+64.9%

DanaherDHR

$1.32B+1.8%

Agilent TechnologiesA

$277M+25.3%

Bio-Rad LaboratoriesBIO

$108.1M-16.8%

Other financials

Income statement

See full

Revenue$194.3M+14.8%

Gross profit$108.3M+18.5%

Operating income$15.9M+142%

Net income$8.3M+42.9%

EPS (diluted)$0.15+50.0%

Balance sheet

See full

Cash & equivalents$582.7M-16.4%

Total debt$687.6M+346%

Total equity$2.1B+6.0%

Total assets$2.9B+2.8%

Cash flow

See full

CapEx$4.7M+32.2%

Free cash flow$23.6M+106%

Valuation

See full

Market cap$7.45B-7.1%

Enterprise value$7.55B+2.1%

P/E144.9×—

P/S10.1×-0.1×

Profitability

See full

Gross margin49.5%+2.7pp

Operating margin1.5%-14.0pp

Net margin17.1%-3.7pp

FCF margin21.2%+6.1pp

Returns & leverage

See full

Return on equity2.5%+1.9pp

Debt / equity0.3×+0.2×

Current ratio9.2×+2.4×

Where this comes from

Reported directly by Repligen in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: Repligen’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Repligen's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Repligen's operating cash flow?: Repligen (RGEN) reported operating cash flow of $28.3M in Q1 2026.
How has Repligen's operating cash flow changed year-over-year?: Repligen's operating cash flow increased by 88.6% year-over-year, from $15.01M to $28.3M.
What is the long-term trend for Repligen's operating cash flow?: Over 4 years (2021 to 2025), Repligen's operating cash flow has grown at a -0.3% compound annual growth rate (CAGR), from $119.02M to $117.42M.
What does operating cash flow mean?: Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.